Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
globenewswire.com
Want to monitor APTIV.COM?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor APTIV.COMNo company information available
No data available